137 related articles for article (PubMed ID: 24200932)
1. Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.
Liu J; Liu Q; Yang X; Xu S; Zhang H; Bai R; Yao H; Jiang J; Shen M; Wu X; Xu J
Bioorg Med Chem; 2013 Dec; 21(24):7742-51. PubMed ID: 24200932
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Wan Y; Wallinder C; Plouffe B; Beaudry H; Mahalingam AK; Wu X; Johansson B; Holm M; Botoros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2004 Nov; 47(24):5995-6008. PubMed ID: 15537354
[TBL] [Abstract][Full Text] [Related]
3. Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening.
Siddiqui AA; Mishra R; Shaharyar M; Husain A; Rashid M; Pal P
Bioorg Med Chem Lett; 2011 Feb; 21(3):1023-6. PubMed ID: 21211966
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
Bai R; Wei Z; Liu J; Xie W; Yao H; Wu X; Jiang J; Wang Q; Xu J
Bioorg Med Chem; 2012 Aug; 20(15):4661-7. PubMed ID: 22750010
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new fluorine substituted derivatives as angiotensin II receptor antagonists with anti-hypertension and anti-tumor effects.
Da YJ; Yuan WD; Xin T; Nie YY; Ye Y; Yan YJ; Liang LS; Chen ZL
Bioorg Med Chem; 2012 Dec; 20(24):7101-11. PubMed ID: 23122933
[TBL] [Abstract][Full Text] [Related]
6. Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
Ashton WT; Chang LL; Flanagan KL; Hutchins SM; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ; Chen TB; Faust KA
J Med Chem; 1994 Aug; 37(17):2808-24. PubMed ID: 8064808
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
Nie YY; Da YJ; Zheng H; Yang XX; Jia L; Wen CH; Liang LS; Tian J; Chen ZL
Bioorg Med Chem; 2012 Apr; 20(8):2747-61. PubMed ID: 22410249
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents.
Ali KA; Ragab EA; Farghaly TA; Abdalla MM
Acta Pol Pharm; 2011; 68(2):237-47. PubMed ID: 21485297
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor.
Kakefuda A; Suzuki T; Tobe T; Tsukada J; Tahara A; Sakamoto S; Tsukamoto S
J Med Chem; 2002 Jun; 45(12):2589-98. PubMed ID: 12036368
[TBL] [Abstract][Full Text] [Related]
12. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
[TBL] [Abstract][Full Text] [Related]
13. N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation.
Zhu W; Bao X; Ren H; Da Y; Wu D; Li F; Yan Y; Wang L; Chen Z
Eur J Med Chem; 2016 Jun; 115():161-78. PubMed ID: 27017546
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Peptides as AT2 Receptor Agonists.
Hallberg M; Sävmarker J; Hallberg A
Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY
Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484
[TBL] [Abstract][Full Text] [Related]
17. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
Murugaiah AM; Wu X; Wallinder C; Mahalingam AK; Wan Y; Sköld C; Botros M; Guimond MO; Joshi A; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2012 Mar; 55(5):2265-78. PubMed ID: 22248302
[TBL] [Abstract][Full Text] [Related]
18. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
[TBL] [Abstract][Full Text] [Related]
20. Studies on nonpeptide angiotensin II receptor antagonists. I. Synthesis and biological evaluation of pyrazolo[1,5-b][1,2,4]triazole derivatives with alkyl substituents.
Okazaki T; Suga A; Watanabe T; Kikuchi K; Kurihara H; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa U
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):69-78. PubMed ID: 9468638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
